✓ Last verified: February 14, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: One of Alabama’s largest and most established psychiatric practices — offering Spravato alongside TMS and Vagal Nerve Stimulation under a full team of 20+ psychiatrists, 20+ nurse practitioners, and 40+ psychologists with hospital affiliations at 7 Alabama facilities.
| Review Scores | One of Alabama’s largest psychiatric practices with clinicians on staff at 7 Alabama hospitals |
| Location | Birmingham, AL |
| Address | 2200 Lakeshore Dr, Suite 150, Birmingham, AL 35209 |
| Phone | (205) 871-6926 |
| Website | grayson.associates |
| Treatments | Spravato (Esketamine), Transcranial Magnetic Stimulation (TMS), Vagal Nerve Stimulation, Psychiatric Medication Management, Psychotherapy |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder, Bipolar Depression, Anxiety Disorders, PTSD, OCD |
| Cost | Contact for pricing |
| Insurance | Most major insurance plans accepted |
| Clinical Lead | Dr. Garry Grayson (founder), Dr. Tiffany Andry (Homewood), Dr. Armand Schachter (TRD specialist — Spravato, TMS, VNS) |
HealingMaps Take: Grayson & Associates is the institutional anchor of Birmingham psychiatric care. Founded by Dr. Garry Grayson decades ago, the practice has grown into one of Alabama’s largest mental health groups, with 20+ psychiatrists, 20+ nurse practitioners, nearly 40 psychologists, and over 20 licensed counselors spread across multiple Birmingham-area locations. Their clinicians hold privileges at seven Alabama hospitals, which is a marker of clinical rigor and community integration that standalone ketamine clinics simply can’t match. For patients with treatment-resistant depression, Dr. Armand Schachter at the Galleria location specializes in the interventional psychiatric suite — Spravato, TMS, and Vagal Nerve Stimulation — giving patients multiple evidence-based options if one modality doesn’t produce the desired response. The scale of the practice also means patients benefit from integrated care: a single intake can lead to psychiatry, therapy, Spravato, TMS, or medication management depending on what’s clinically indicated. Insurance coverage is a major plus — most major plans are accepted, which is increasingly rare in the interventional psychiatry space. For Birmingham patients who want Spravato or TMS inside a traditional, insurance-friendly psychiatric medical home, Grayson is the default choice.
Market Position: Grayson & Associates is a Spravato-certified clinic in the Birmingham metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. Grayson & Associates has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Jefferson County, AL, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
Published IV ketamine pricing runs 15–25% higher than what patients actually pay: the median published rate is $525 versus a patient-reported median of $350. Patients who ask about sliding-scale or package pricing often find meaningful flexibility. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 4-question summary is matched to the protocols and conditions Grayson & Associates treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Grayson & Associates offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Grayson & Associates treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Grayson & Associates treats PTSD. Spravato can be used for trauma. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Grayson & Associates treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply